Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083811![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083839![]() (2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083823![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083797![]() (2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083803![]() (2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 7.30 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083836![]() (2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083807![]() (2-(3,4-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083810![]() (2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083837![]() (2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083836![]() (2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083812![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083833![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083811![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083802![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alphaV-beta3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083793![]() (2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083809![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083814![]() (3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of adhesion of integrin beta3-transfected HEK293 cells to fibrinogen | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083785![]() (3-({5-[3-(1H-Imidazol-2-ylcarbamoyl)-propyl]-4,5-d...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083799![]() (2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083805![]() (2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083812![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083799![]() (2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083813![]() (3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083801![]() (2-Benzyloxycarbonylamino-3-({1-[2-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083816![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083828![]() (2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083794![]() (3-({1-[2-(1H-Imidazol-2-ylcarbamoyl)-ethyl]-1H-ind...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083821![]() (3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083814![]() (3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083821![]() (3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of adhesion of integrin beta3-transfected HEK293 cells to fibrinogen | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083832![]() (2-Benzyloxycarbonylamino-3-({1-[3-(1H-imidazol-2-y...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083810![]() (2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083797![]() (2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083823![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083833![]() (3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083798![]() (2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083831![]() (2-(4-tert-Butyl-benzenesulfonylamino)-3-({1-[3-(1H...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083805![]() (2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083834![]() (2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083804![]() (3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083813![]() (3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083815![]() (2-Isobutoxycarbonylamino-3-({1-[3-(pyridin-2-ylami...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083795![]() (2-Benzyloxycarbonylamino-3-({1-[4-(4,5-dihydro-1H-...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbition of Vitronectin receptor (alpha V beta 3) binding | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083837![]() (2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50408870![]() (CHEMBL2111217) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083798![]() (2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083817![]() (2-Benzyloxycarbonylamino-3-({1-[3-(pyridin-2-ylami...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083800![]() (2-(Butane-1-sulfonylamino)-3-({1-[3-(pyridin-2-yla...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-V/beta-3 (Homo sapiens (Human)) | BDBM50083829![]() (3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assay | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50083834![]() (2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP) | J Med Chem 43: 41-58 (2000) BindingDB Entry DOI: 10.7270/Q21G0KG2 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 88 total ) | Next | Last >> |